Display options
Share it on

Hepat Mon. 2012 Nov;12(11):e7359. doi: 10.5812/hepatmon.7359. Epub 2012 Nov 14.

Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients.

Hepatitis monthly

Alicja E Grzegorzewska

Affiliations

  1. Department of Nephrology, Transplantology and Internal Diseases, Pozna? University of Medical Sciences, Pozna?, Poland.

PMID: 23326280 PMCID: PMC3546461 DOI: 10.5812/hepatmon.7359

Abstract

CONTEXT: Hepatitis B vaccination of hemodialysis patients is performed all over the world. There are also recommendations from world health organizations to vaccinate patients with chronic kidney disease (CKD) prior dialysis commencement, but the implementation of a hepatitis B vaccination program is less common and not well organized.

EVIDENCE ACQUISITION: This review article summarizes data indicating why, when and how to vaccinate CKD patients before they start renal replacement therapy. Publication for this review was bringing into being from PubMed.

RESULTS: There is an agreement in the nephrological societies and among clinicians and scientists that CKD patients should be vaccinated in early stages of their disease, because a higher glomerular filtration rate is more likely to be associated with the responsiveness to vaccination. Schedules of vaccination and optimal vaccine doses are still being investigated. Differences in data with respect to these problems may result from comparisons of various vaccine doses and vaccination schedules without reference to one gold standard, variations in patients` clinical status and glomerular filtration rate, and also the small groups of the affected patients make statistical analysis non-conclusive. A titer of antibodies to surface antigen of hepatitis B virus (anti-HBs) > 10 IU/L or ≥ 10 IU/L is commonly considered as a marker of seroconversion to anti-HBs positivity after vaccination in both non-dialyzed and dialyzed patients. In advanced CKD, vaccine-induced serconversion rate is seldom observed in more than 90% of vaccinees. Various strategies have been utilized in order to increase vaccine-induced seroconversion rate in patients with advanced CKD. Changing the injection mode, the use of adjuvants and immunostimulants to improve the immunogenicity of existing recombinant hepatitis B vaccines, introduction of mammalian-cell derived pre-S/S HBV vaccines (third-generation vaccines) were tried in order to improve the immunization rate.

CONCLUSIONS: There are a substantial number of non-responders to the hepatitis B vaccine among CKD patients. Therefore, successful prevention of hepatitis B virus transmission and spread will only be attained when hepatitis B vaccination is applied together with full implementation of appropriate infection control procedures.

Keywords: Hepatitis B Virus; Kidney Disease; Vaccination

References

  1. Kidney Blood Press Res. 2012;35(1):1-8 - PubMed
  2. Hum Vaccin. 2011 Sep;7(9):913-8 - PubMed
  3. Am J Kidney Dis. 1999 Feb;33(2):356-60 - PubMed
  4. Lancet. 1994 Sep 24;344(8926):856-7 - PubMed
  5. Vaccine. 2011 Feb 1;29(6):1159-66 - PubMed
  6. Vopr Virusol. 1994 Sep-Oct;39(5):226-9 - PubMed
  7. N Engl J Med. 1985 Aug 29;313(9):579-80 - PubMed
  8. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1105-12 - PubMed
  9. Przegl Epidemiol. 2008;62(1):29-37 - PubMed
  10. Vaccine. 2010 May 14;28(22):3773-7 - PubMed
  11. Ann Intern Med. 1976 Oct;85(4):427-30 - PubMed
  12. Clin Nephrol. 2002 Oct;58(4):301-4 - PubMed
  13. Can Med Assoc J. 1975 Apr 19;112(8):968, 971 - PubMed
  14. Presse Med. 1994 Feb 12;23(6):277-80 - PubMed
  15. MMWR Morb Mortal Wkly Rep. 1982 Jun 25;31(24):317-22, 327-8 - PubMed
  16. Hepatology. 2009 Sep;50(3):661-2 - PubMed
  17. BMC Nephrol. 2012 Aug 03;13:75 - PubMed
  18. Vnitr Lek. 2011 Oct;57(10):808-14 - PubMed
  19. Hepat Mon. 2012 May;12(5):344-8 - PubMed
  20. Nephrol Dial Transplant. 1996 Aug;11(8):1559-63 - PubMed
  21. Nephrol Dial Transplant. 1995;10(9):1780 - PubMed
  22. Am J Nephrol. 1996;16(2):95-7 - PubMed
  23. J Hepatol. 1990 Nov;11(3):385-7 - PubMed
  24. G Ital Nefrol. 2011 Sep-Oct;28(5):525-30 - PubMed
  25. Kidney Int. 1991 Jul;40(1):121-8 - PubMed
  26. J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8 - PubMed
  27. Ren Fail. 2011;33(3):276-9 - PubMed
  28. Am J Kidney Dis. 1994 Apr;23(4):537-42 - PubMed
  29. Postgrad Med J. 2002 Sep;78(923):538-40 - PubMed
  30. J Egypt Public Health Assoc. 2000;75(3-4):257-75 - PubMed
  31. Nephrol Dial Transplant. 1994;9(12):1765-8 - PubMed
  32. J Infect Dis. 1988 Feb;157(2):332-7 - PubMed
  33. Arch Virol Suppl. 1993;8:123-31 - PubMed
  34. PLoS One. 2008 Mar 26;3(3):e1898 - PubMed
  35. Vox Sang. 1979;36(6):353-5 - PubMed
  36. Nephron. 1992;61(3):266-8 - PubMed
  37. Clin Nephrol. 2007 Oct;68(4):228-34 - PubMed
  38. Vaccine. 1993 Sep;11(12):1229-32 - PubMed
  39. Semin Dial. 2005 Jan-Feb;18(1):52-61 - PubMed
  40. Ann Intern Med. 2005 Mar 1;142(5):333-41 - PubMed
  41. Hepat Mon. 2011 Oct;11(10):816-20 - PubMed
  42. J Ren Nutr. 2010 Sep;20(5 Suppl):S109-17 - PubMed
  43. J Med Virol. 2008 Feb;80(2):217-24 - PubMed
  44. Vaccine. 2005 Jul 14;23(32):4142-7 - PubMed
  45. Nephrol Dial Transplant. 2011 Mar;26(3):970-6 - PubMed
  46. Aliment Pharmacol Ther. 2006 Aug 1;24(3):497-506 - PubMed
  47. Nephrol Dial Transplant. 2009 May;24(5):1598-603 - PubMed
  48. Vaccine. 1993;11(4):397-9 - PubMed
  49. Vaccine. 1990 Mar;8 Suppl:S63-8; discussion S79-80 - PubMed
  50. Hum Immunol. 1998 Apr;59(4):212-8 - PubMed
  51. Rev Gastroenterol Peru. 2005 Oct-Dec;25(4):320-7 - PubMed
  52. N Engl J Med. 1989 Sep 14;321(11):708-12 - PubMed
  53. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1053-62 - PubMed
  54. Minerva Med. 2011 Dec;102(6):469-74 - PubMed
  55. Int Immunol. 2000 Feb;12(2):151-60 - PubMed
  56. J Immunol. 1998 Oct 1;161(7):3400-7 - PubMed
  57. J Epidemiol Community Health. 1992 Dec;46(6):587-94 - PubMed
  58. J Zhejiang Univ Sci. 2004 Apr;5(4):467-71 - PubMed
  59. Vaccine. 1996 Aug;14(11):1019-27 - PubMed
  60. Hepatology. 1985 Nov-Dec;5(6):1088-90 - PubMed
  61. Vaccine. 2012 Mar 16;30(13):2295-300 - PubMed
  62. Kidney Int. 2001 Dec;60(6):2385-91 - PubMed
  63. Immunology. 2003 Sep;110(1):131-40 - PubMed
  64. Gastroenterology. 1977 Feb;72(2):290-6 - PubMed
  65. Hum Immunol. 1988 May;22(1):9-17 - PubMed
  66. JAMA. 1988 Jan 15;259(3):365-9 - PubMed
  67. Kidney Int. 2004 Aug;66(2):614-21 - PubMed
  68. Asian Pac J Allergy Immunol. 2007 Dec;25(4):233-42 - PubMed
  69. Am J Nephrol. 2000 Jan-Feb;20(1):1-11 - PubMed
  70. J Immunol. 1976 Dec;117(6):2260-2 - PubMed
  71. Hepatobiliary Pancreat Dis Int. 2002 May;1(2):228-31 - PubMed
  72. Nephron Clin Pract. 2010;114(3):c194-203 - PubMed
  73. Eur J Immunol. 1992 Jul;22(7):1899-905 - PubMed
  74. HIV Med. 2008 Aug;9(7):519-25 - PubMed
  75. Nephron. 1988;50(2):133-6 - PubMed
  76. J Clin Invest. 1992 Dec;90(6):2543-7 - PubMed
  77. J Med Primatol. 1999 Aug-Oct;28(4-5):214-23 - PubMed
  78. Nephrol Dial Transplant. 1995;10(2):240-6 - PubMed
  79. Vaccine. 2012 Jan 20;30(5):931-5 - PubMed
  80. J Immunol. 1986 Jul 1;137(1):315-22 - PubMed
  81. Kidney Int. 2005 Mar;67(3):1136-41 - PubMed
  82. Nephrol Dial Transplant. 2002;17 Suppl 7:72-87 - PubMed
  83. J Assoc Physicians India. 1999 Feb;47(2):183-5 - PubMed
  84. Am J Kidney Dis. 2003 Dec;42(6):1184-92 - PubMed
  85. N Engl J Med. 1984 Aug 23;311(8):496-501 - PubMed
  86. Nephrology (Carlton). 2007 Aug;12(4):399-405 - PubMed
  87. J Med Assoc Thai. 2003 Dec;86(12):1122-7 - PubMed
  88. Nephrology (Carlton). 2008 Oct;13(5):376-9 - PubMed

Publication Types